BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11891470)

  • 1. Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease.
    Takatsu H; Wada H; Maekawa N; Takemura M; Saito K; Fujiwara H
    Nucl Med Commun; 2002 Feb; 23(2):161-6. PubMed ID: 11891470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism.
    Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y; Kajiyama S; Saji H
    Nucl Med Biol; 2006 Jan; 33(1):37-42. PubMed ID: 16459257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism.
    Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y
    Nucl Med Biol; 2009 Aug; 36(6):623-9. PubMed ID: 19647168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
    Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
    Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
    Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
    Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
    Reinhardt MJ; Jüngling FD; Krause TM; Braune S
    Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac sympathetic nerve function assessed by [131I]metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs.
    Takatsu H; Duncker CM; Arai M; Becker LC
    J Nucl Cardiol; 1997; 4(1 Pt 1):35-41. PubMed ID: 9138838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
    Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):993-7. PubMed ID: 16261676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.
    Choi MH; Yoon JH; Yong SW
    J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myocardial 123I-MIBG uptake in Parkinson's disease.
    Iwasa K; Nakajima K; Yoshikawa H; Tada A; Taki J; Takamori M
    Acta Neurol Scand; 1998 May; 97(5):303-6. PubMed ID: 9613559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic Syrian hamsters using the renin-angiotensin system.
    Takatsu H; Uno Y; Fujiwara H
    J Nucl Med; 1995 Jun; 36(6):1055-61. PubMed ID: 7769428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.
    Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T
    J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease.
    Yoshita M; Hayashi M; Hirai S
    Nucl Med Commun; 1998 Feb; 19(2):137-42. PubMed ID: 9548197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
    Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
    Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
    Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):438-42. PubMed ID: 15821963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.